Bausch+Ströbel and Brüel & Kjær Vibro
Bausch+Ströbel develops predictive maintenance for its equipment with AVEVA CONNECT and PI System
Bausch+Ströbel, a manufacturer of pharmaceutical filling and packaging equipment, wanted to make a step where precision is paramount more reliable: an unplanned stoppage can mean losing an entire batch. However, most filling lines on the market are not monitored with data, and the know-how of maintenance engineers is gradually eroding. In partnership with condition monitoring specialist B&K Vibro, Bausch+Ströbel developed a Condition Monitoring as a Service offering based on AVEVA PI System and AVEVA CONNECT. The solution combines vibration data and machine data to generate information that customers can act on directly. The benefits are significant: a simple, scalable, non-intrusive monitoring platform, optimized maintenance cycles, fewer unplanned stoppages and higher productivity. Avoiding a single 15-hour stoppage on one asset represents up to €590,000 in potential savings, demonstrating the major financial impact of this innovation for the pharmaceutical industry.
Integrated AVEVA software
AVEVA PI System
Bausch+Ströbel and Brüel & Kjær Vibro use AVEVA PI System to collect data from their pharmaceutical equipment. This solution provides real-time visibility into performance and facilitates predictive maintenance.
Find out more
AVEVA CONNECT
These partners use AVEVA CONNECT to share vibration and performance data. This cloud-based platform enables remote monitoring and optimization of equipment maintenance.
Find out more
Testimonials
FAQ
What is the Condition Monitoring as a Service offering developed with AVEVA PI System?
Bausch+Ströbel and Brüel & Kjær Vibro developed a Condition Monitoring as a Service offering built on AVEVA PI System and CONNECT. The service combines machine vibration data and operational data to provide pharmaceutical customers with actionable insights into the health of their filling equipment. This approach turns a product asset into a recurring value-added service, a business model increasingly popular with industrial equipment manufacturers looking to build customer loyalty.
Why is condition monitoring critical for pharmaceutical filling lines?
Most pharmaceutical filling lines on the market are not data-monitored, exposing manufacturers to unexpected stoppages that can result in the loss of an entire batch of medicine. AVEVA PI System changes the game by continuously collecting vibration and machine data, detecting anomalies early and alerting maintenance teams. Avoiding a single 15-hour stoppage on one asset can save up to €590,000, demonstrating the major financial impact of this innovation.
How does AVEVA CONNECT make it possible to share monitoring data with customers?
AVEVA CONNECT, a cloud platform, acts as a bridge between Bausch+Ströbel machines installed at pharmaceutical customers' sites and B&K Vibro's analyses. Data is collected, contextualized and presented in a secure environment accessible to both parties. This service approach allows Bausch+Ströbel to offer differentiated after-sales support while protecting its customers' intellectual property. The cloud thus becomes a strategic channel for industrial relationships in the life sciences.
How can the erosion of pharmaceutical maintenance engineers' expertise be offset?
The expertise of pharmaceutical maintenance engineers is gradually eroding with retirements and the difficulty of passing on tacit experience. AVEVA PI System captures, structures and democratizes the patterns of normal and abnormal equipment behavior. New technicians gain access to an objective knowledge base, supported by automated vibration analysis. The platform thus becomes a reusable repository of expertise that complements human training, essential in the pharmaceutical industry, where stoppages are extremely costly.
What ROI can a pharmaceutical manufacturer expect from AVEVA condition monitoring?
The ROI of Condition Monitoring as a Service based on AVEVA PI System and CONNECT is measured mainly in avoided unplanned stoppages: potential savings of €590,000 for a single 15-hour stoppage avoided. Multiplied by the annual frequency of incidents and the number of lines monitored, this ROI quickly becomes very significant. Added to this are optimized maintenance cycles, reduced spare parts inventories and faster time to market for medicines. It is a strategic investment in pharmaceutical performance.